- Breast Cancer Conqueror - https://breastcancerconqueror.com -

The Cancer BioShield™: Is it the New Way to Heal Cancer?

Quick Read:

“We are entering a new era in oncology where the goal is not only to target the tumor but to protect and empower the immune system itself.” – Dr. Soon-Shiong

When it comes to your health, your immune system is one of the main characters. And yet, many (and often 100% necessary) cancer treatments like chemotherapy and radiation often leave your body’s defense system severely compromised, wiping out the very cells your body needs to fight, recover, and thrive. THIS is one of the main reasons why integrative oncology and the 7 Essentials System® [1] are critical in your mind, body, and soul healing plan.

And now, there’s a new superhero, Cancer BioShield™, that can give you the happy and healthy ending you are seeking. 

What is the Cancer BioShield platform?

Developed by Dr. Patrick Soon-Shiong, a trailblazer in cancer immunotherapy and founder of ImmunityBio [2], the Cancer BioShield™ platform is designed to rebuild and protect the immune system, especially when it’s being destroyed by cancer and treatments.

The multi-model approach is an emerging reality backed by FDA-authorized therapies, clinical trials, and one visionary mission: to transform cancer care by reversing immune collapse and empowering the body to heal itself from the inside out.

The Cancer BioShield™ Approach

The Cancer BioShield™ uses these three therapies to optimize your immune system. (This info was directly taken from ImmunityBio.com [3].)

If the above was in gibberish to you, here’s what it does: Each part works together to offer a comprehensive, novel, immune-restoring therapeutic platform aimed at not only expanding effector immune cells but also overcoming tumor-mediated immune suppression to support long-term disease control.

In short, it makes your immune system so powerful that it makes it more difficult for cancer and other diseases to grow. If you are undergoing chemotherapy and/or radiation, the Cancer BioShield™ can work in conjunction with your treatment to enhance its effectiveness and reduce side effects.

The Cancer BioShield

Why Does The Cancer BioShield™ Platform Focus on Lymphopenia?

If you don’t know or need a refresher, lymphopenia is the loss of key immune cells such as NK, CD4+, and CD8+ T cells. It’s a common but often overlooked condition that is often caused by chemotherapy, radiation, and some immunotherapies. (Read studies here) [4] This depletion can leave your immune defenses wide open to cancer progression, recurrence, and infections. 

At the heart of the BioShield™ platform is a therapy called ANKTIVA® (nogapendekin alfa inbakicept), an IL-15 superagonist. It works by stimulating the body’s natural killer (NK) cells and T cells—immune warriors that are essential for identifying and eliminating cancer cells. It is the first approved therapy to restore lymphocyte levels by activating and expanding NK and T cells—without increasing immunosuppressive T regulatory cells 7. (This info was directly taken from ImmunityBio.com [3])

For too long, conventional cancer treatments have treated the tumor while ignoring the immune system. The BioShield™ platform flips that script by treating not just the tumor, but the underlying immune collapse that allows disease to progress.

How can I know the Cancer BioShield™ Is Working?

First, you need to know about your ALC: absolute lymphocyte count. It’s a number you can find on any standard CBC blood test. Lymphocytes are a type of white blood cell (WBC) that plays a central role in your immune system, particularly in defending against viruses, bacteria, and abnormal cells (like breast cancer).

Studies [5] have shown that low lymphocyte levels (lymphopenia) are associated with shorter survival rates; yet this critical number often gets overlooked.

Lymphocytes include:

BioShield’s effectiveness can be tracked through universally utilized simple complete blood count (CBC): increases in absolute lymphocyte count (ALC) reflect ANKTIVA’s lymphocyte-stimulating activity, while reductions in the neutrophil-to-lymphocyte ratio (NLR) demonstrate PD-L1 t-haNK’s immunosuppressive neutrophil targeting. Low ALC and high NLR levels are laboratory measurements that have been extensively reported as predictive biomarkers of poor prognosis with early mortality across all tumor types.

BioShield™ vs. Conventional Immunotherapies

You may have heard of CAR-T therapies or checkpoint inhibitors—two forms of immunotherapy that have gained attention in recent years.

But here’s where BioShield™ stands out:

In short, it’s a new generation of cancer care—less about the destruction of cells, more about the regeneration of healthy ones. It’s an upgrade for your immune system that will help your body stay resilient throughout your long, vibrant life. 

What This Means for You

If you’re navigating breast cancer—or in remission but still feeling vulnerable—here’s what you can do:

Check Your Lymphocyte Count

Ask your doctor to go over your CBC (Complete Blood Count). Pay special attention to your ALC, and discuss with your doctor and/or coach [6] what the optimal levels for you would be. 

Stay Informed on ANKTIVA and BioShield™

While it’s not yet widely available, Expanded Access programs are growing. Consider talking to your oncologist about whether you may qualify.

Support Your Immune System Daily

Even as science advances, your daily choices still matter more than you think! Nourish your immune system with: [7]

Other Safe, Effective, and Minimally Invasive Breast Cancer Treatments

At Breast Cancer Conqueror®, we are all about OPTIONS and helping you make the most empowered and informed decisions possible about your healing journey. Below are a few more therapies to consider:

Take Charge of Your Healing

Dr. Soon-Shiong’s BioShield™ platform represents more than a therapy; it’s a paradigm shift. It changes the conversation from “fighting cancer” to fortifying your body.

It perfectly aligns with our mission of the whole person, not just attacking the tumor. This exciting new wave of immune-centered therapies confirms what we’ve known all along: Your body is wise. It wants to heal. You just have to give it the right tools.

And speaking of tools, if you have not taken our on-demand intro course, Conquering Breast Cancer Together: A Balanced Approach to YOUR Healing Journey [19], now is the time!